Last update 10 May 2025

CN118344358

Patent Mining

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
HPK1
Action
inhibitors
Mechanism
HPK1 inhibitors(Mitogen-activated protein kinase kinase kinase kinase 1 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [2]
Active Indication
Hemic and Lymphatic DiseasesImmune System DiseasesInflammation+ [2]
Inactive Indication-
Originator Organization
Shanghai Institute of Organic Chemistry
Livzon Pharmaceutical Group, Inc.Livzon Pharmaceutical Group, Inc.
Active Organization
Livzon Pharmaceutical Group, Inc.Livzon Pharmaceutical Group, Inc.Shanghai Institute of Organic Chemistry
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with CN118344358
Login to view more data
100 Translational Medicine associated with CN118344358
Login to view more data
100 Patents (Medical) associated with CN118344358
Login to view more data
100 Deals associated with CN118344358
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hemic and Lymphatic DiseasesDiscovery-
Livzon Pharmaceutical Group, Inc.Livzon Pharmaceutical Group, Inc.
16 Jul 2024
Hemic and Lymphatic DiseasesDiscovery-
Shanghai Institute of Organic Chemistry
16 Jul 2024
Immune System DiseasesDiscovery-
Shanghai Institute of Organic Chemistry
16 Jul 2024
Immune System DiseasesDiscovery-
Livzon Pharmaceutical Group, Inc.Livzon Pharmaceutical Group, Inc.
16 Jul 2024
InflammationDiscovery-
Livzon Pharmaceutical Group, Inc.Livzon Pharmaceutical Group, Inc.
16 Jul 2024
InflammationDiscovery-
Shanghai Institute of Organic Chemistry
16 Jul 2024
NeoplasmsDiscovery-
Livzon Pharmaceutical Group, Inc.Livzon Pharmaceutical Group, Inc.
16 Jul 2024
NeoplasmsDiscovery-
Shanghai Institute of Organic Chemistry
16 Jul 2024
Skin and Musculoskeletal DiseasesDiscovery-
Shanghai Institute of Organic Chemistry
16 Jul 2024
Skin and Musculoskeletal DiseasesDiscovery-
Livzon Pharmaceutical Group, Inc.Livzon Pharmaceutical Group, Inc.
16 Jul 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free